marwa mahmoud abdelrady

Dr. marwa mahmoud abdelrady

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in Minerva Anestesiologica
Verified
Journal Article
Closed access
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
AOAyman M. Osman
Ayman M. Osman
GEGhada M. Abo Elfadl
Ghada M. Abo Elfadl
HAHaitham M. Ahmed
Haitham M. Ahmed
SSSherif Sayed
Sherif Sayed
WAWesam N. Ali
Wesam N. Ali
Article: Effects of intravenous single-bolus lidocaine infusion versus intravenous single-bolus magnesium sulfate infusion on postoperative pain, emotional status, and quality of life in patients undergoing spine fusion surgery: a randomized study - Minerva Anestesiologica 2024 May;90(5):397-408 - Minerva Medica - Journals

11 January 2022 in Egyptian Journal of Anaesthesia
Verified
Journal Article
Open access
GAGhada Mohammad AboElfadl
Ghada Mohammad AboElfadl
WAWesam Nashat Ali
Wesam Nashat Ali
FAFatma Jad Elrab Askar
Fatma Jad Elrab Askar
AOAyman Mamdouh Osman
Ayman Mamdouh Osman
NDNoha Hassan Daghash
Noha Hassan Daghash
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
Sacroiliac joint pain (SIJP) is an important cause of low back pain and seriously affects the patients’ quality of life. Therefore, it is urgent to find effective treatment methods. The goal of our...

6 October 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
AHAlaa Thabet Hassan
Alaa Thabet Hassan
AEAlaa E. Abd Elmoniem
Alaa E. Abd Elmoniem
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
MMMona Sallam Embarek Mohamed
Mona Sallam Embarek Mohamed
MEMohamed El-Mokhtar
Mohamed El-Mokhtar
SKSoheir M. Kassem
Soheir M. Kassem
Background: As COVID-19 has neither a standard treatment protocol nor guidelines, there are many treatment protocols for anti-inflammatory corticosteroids and anti-coagulations for severe COVID-19 pneumonia patients. This study aimed to assess the most suitable modality in this high-risk group. Methods: A prospective, experimental study design was adopted that included 123 severe COVID-19 pneumonia patients admitted at Assiut University Hospital. Patients were divided into three groups according to a combined corticosteroid and anticoagulants therapy protocol. Group A included 32 patients, group B included 45 patients, and group C included 46 patients. Assessment of cases was conducted according to the treatment type and duration, weaning duration from oxygen therapy, length of hospital and ICU stay, and complications during treatment. Three months follow-up after discharge was performed. Results: the three patient groups showed significant differences regarding the 3-month outcome, whereas Group C showed the highest cure rate, lowest lung fibrosis, and lowest mortality rate over the other two groups. The in-hospital outcome, the development of pulmonary embolism, bleeding, hematoma, acute kidney disease, and myocardial infarction showed a significant difference between groups (p values < 0.05). Mortality predictors among severe COVID-19 patients by multivariable Cox hazard regression included treatment modality, history of comorbid diseases, increased C reactive protein, high neutrophil-lymphocyte ratio, and shorter ICU and hospital stay. Conclusion: the use of combined methylprednisolone and therapeutic Enoxaparin, according to a flexible protocol for COVID-19 patients with severe pneumonia, had two benefits; the prevention of disease complications and improved clinical outcome.

11 June 2022 in Brazilian Journal of Anesthesiology (English Edition)
Verified
Journal Article
Open access
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
GFGolnar Mohammed Fathy
Golnar Mohammed Fathy
MAMohamed Abdelrady Mohamed Abdallah
Mohamed Abdelrady Mohamed Abdallah
WAWesam Nashat Ali
Wesam Nashat Ali
Many adjuvants are added to prolong the effects of spinal analgesia. We investigated the postoperative analgesic efficacy of the addition of midazolam or fentanyl to intrathecal levobupivacaine in women undergoing cesarean delivery. Eighty patients were randomly assigned to two groups (n = 40). Group M received 10 mg of 0.5% levobupivacaine plus 2 mg of midazolam. Group F received 10 mg of 0.5% levobupivacaine plus 25 μg of fentanyl. Assessments included motor and sensory block, APGAR score, time to first request for analgesia, postoperative pain score, total consumption of rescue analgesics, and adverse effects. Sensory blockade was prolonged in Group M compared with Group F (215.58 ± 27.94 vs. 199.43 ± 19.77 min; p = 0.004), with no differences in other characteristics of the spinal block in intraoperative hemodynamics or APGAR score. The mean time to first request for rescue analgesia was longer in Group M (351.45 ± 11.05 min) than in Group F (268.83 ± 10.35 min; p = 0.000). The median total consumption of rescue analgesics in the first 24 hours postoperatively was 30 mg in Group M vs. 60 mg in Group F (p = 0.003). The median Visual Analog Scale (VAS) scores were lower in Group Ethan in Group F from the 8th to the 12th hour postoperatively, with no differences between the groups at other time points. The incidence of adverse effects was higher in Group F than in Group M. Intrathecal midazolam (2 mg) was superior to intrathecal fentanyl (25 μg) in increasing the duration of the sensory blockade and postoperative analgesia with lower postoperative pain scores and decreasing the incidence of adverse effects.

1 January 2021 in Egyptian Journal of Anaesthesia
Verified
Journal Article
Open access
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
GAGhada Mohammad AboElfadl
Ghada Mohammad AboElfadl
EMEkram Abdullah Othman Mohamed
Ekram Abdullah Othman Mohamed
MAMohamed Galal Abdel-Rehim
Mohamed Galal Abdel-Rehim
AAAli Hamdi Ali
Ali Hamdi Ali
WAWesamNashat Ali
WesamNashat Ali
Background: N-methyl-D-aspartate (NMDA) receptors are thought to be for pain memory, and blocking them can help to reduce pain. We aimed to assess the preventive effects of small doses of ketamine administered prior to the skin incision in abdominal surgery, to assess analgesic efficacy and intra-operative and post-operative side effects. Methods: 60 adult patients with ASA I and II who were scheduled for abdominal surgery were randomly divided into two groups in a prospective, double-blind study. Before the skin incision, group K received 1 mg/kg ketamine intravenously, followed by a 0.12 mg/kg/h ketamine infusion till the skin was closed. Instead of ketamine, group C received normal saline. After extubation, both groups received morphine 5 mg IV. The visual analogue scale (VAS) was used to measure analgesic effectiveness at rest and after exercise, as well as the duration to the first analgesic and morphine intake in 24 h, and analyze changes in serum CRP and IL6 levels as indicators of its impact. Also, side effects of opioid or ketamine have been recorded. Results: Within 24 h, patients in the ketamine group had a significantly lower VAS score, a longer time to the first analgesic (326.3 +/- 49.5 minutes), and lower morphine consumption (6.9 +/- 2.91 mg). Also, postoperative interleukin 6 and CRP showed significant difference between the two groups (p <= 0.05). In group K, no side effects were detectable. Conclusion: Ketamine may be a promising drug in low doses that can limit and even prevent worsened inflammation. It also resulted in decreased postoperative opioid use, decreased pain rating, earlier retains of bowel motility, and decreased incidence of side effects.

1 September 2024 in Minerva Anestesiologica
Verified
Journal Article
Closed access
MAmarwa mahmoud abdelrady
marwa mahmoud abdelrady
KLKing H. Lam
King H. Lam
NSNehal Shabaan
Nehal Shabaan
MHManal Hassanien
Manal Hassanien
EMEsam Mokbel
Esam Mokbel
GAGhada M. Aboelfadl
Ghada M. Aboelfadl
BACKGROUND: We hypothesized that ultrasound-guided selective nerve root block could play a role in the prediction of clinical outcomes in patients with multilevel cervical disease following selective anterior cervical discectomy and fusion. METHODS: Patients were randomized to receive ultrasound-guided selected nerve root block as a diagnostic tool (study group) or not (control group), but both groups had surgery. Pain evaluation for arm and neck pain was recorded. The Visual Analog Scale (VAS) pain scores, Neck Disability Index, and MRI results were compared between groups. They were assessed every two weeks for three months, postoperatively. The percentage of patients who showed >= 50% reduction in their pain levels and a VAS rating of <= 2 was deemed an acceptable surgical outcome. RESULTS: Patients in the study group had significantly lower VAS scores for pain intensity than control patients at nearly all periods. This baseline pain improved significantly in the study group. A more significant proportion of patients in the study group showed a >= 50% reduction in their pain scores from baseline at weeks four, eight, and 12, and this difference was significantly lower than in the control group (P<0.05). The study group improved significantly over baseline in Neck Disability Index scores compared to control patients. Patients were highly satisfied with no significant adverse events in the study group. CONCLUSIONS: In patients with multilevel cervical disease, ultrasound-guided selective nerve root block is an excellent, safe, non-radiating, and reliable test to determine the appropriate level for operation.